Raffles Medical’s profit after tax soars 71.7% YoY to $143.7m in FY22
The company attributed the increase to the return of foreign patients.
Raffles Medical Group saw a 71.7% YoY increase in its profit after tax (PAT) for FY22 following the return of foreign patients seeking medical treatment in Singapore.
Based on its latest financial statement, Raffles Medical Group’s profit after tax in FY22 was $143.7m.
During the financial year, the company also recorded a 5.9% YoY higher revenue of $766.5m.
Given the increase in its profit after tax and revenue, as well as a healthy cash position of $252.1m, the group's directors proposed a final ordinary dividend of $0.038 per share for FY22.
The final dividend for FY22 represents a 35.7% YoY increase from FY21.
It’s high time for property developers to implement effective anti-money laundering requirements
Transforming the Retail Horizon: Experiential Retail and Digitalisation key in driving post-pandemic growth
The Impact of the ABSD rate hike and property buyer tax on real estate investments